Achieve Life Sciences (ACHV) Prepaid Assets (2010 - 2026)
Achieve Life Sciences' (ACHV) quarterly Prepaid Assets came in at $125000.0 in Q1 2026, down 92.88% YoY from $1.8 million in Q1 2025, and down 35.23% on a QoQ basis from $193000.0 in Q4 2025.
Analysis
Achieve Life Sciences (ACHV) Prepaid Assets (2010 - 2026) Analysis & Trends
Achieve Life Sciences (ACHV) has 17 years of Prepaid Assets data on file, last reported at $125000.0 in Q1 2026.
- Quarterly Prepaid Assets fell 92.88% year-over-year to $125000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $125000.0 (down 92.88% YoY) and the FY2025 annual result came in at $193000.0, down 90.84% from the prior year.
- Prepaid Assets declined to $125000.0 in Q1 2026, from $193000.0 in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $2.6 million in Q3 2024 to a low of $125000.0 in Q1 2026.
- A 5-year average of $1.6 million and a median of $1.5 million in 2025 frame the typical range for Prepaid Assets.
- Annual changes were most pronounced in 2022 — Prepaid Assets surged 238.84% — and 2026, when it tumbled 92.88%.
- Tracing ACHV's Prepaid Assets over 5 years: stood at $2.5 million in 2022, then plunged by 46.01% to $1.3 million in 2023, then jumped by 59.02% to $2.1 million in 2024, then plunged by 90.84% to $193000.0 in 2025, then slumped by 35.23% to $125000.0 in 2026.
- The last three Prepaid Assets figures came in at $125000.0 (Q1 2026), $193000.0 (Q4 2025), and $1.9 million (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Achieve Life Sciences | 369.90 Mn | 369.90 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 805,000.00 |
| Mar 31, 2026 | 1.67 Mn |
| Dec 31, 2025 | 3.29 Mn |
| Sep 30, 2025 | 1.94 Mn |
| Jun 30, 2025 | 1.51 Mn |
| Mar 31, 2025 | 1.76 Mn |
| Dec 31, 2024 | 2.11 Mn |
| Sep 30, 2024 | 2.62 Mn |
| Jun 30, 2024 | 1.21 Mn |
| Mar 31, 2024 | 1.31 Mn |
| Dec 31, 2023 | 1.33 Mn |
| Sep 30, 2023 | 1.90 Mn |
| Jun 30, 2023 | 958,000.00 |
| Mar 31, 2023 | 1.62 Mn |
| Dec 31, 2022 | 2.45 Mn |
| Sep 30, 2022 | 2.62 Mn |
| Jun 30, 2022 | 1.46 Mn |
| Mar 31, 2022 | 1.36 Mn |
| Dec 31, 2021 | 1.42 Mn |
| Sep 30, 2021 | 1.27 Mn |